| Literature DB >> 21712760 |
Jiří Václavík1, Petr Kačer, Marek Kuzma, Libor Cervený.
Abstract
Methods for the asymmetric transferEntities:
Mesh:
Substances:
Year: 2011 PMID: 21712760 PMCID: PMC6264677 DOI: 10.3390/molecules16075460
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The basic set of η6-arene/N-sulfonyldiamine-RuII catalysts.
The basic set of η6-arene/N-sulfonyldiamine-RuII catalysts and their representative reactions.
| Entry | Catalyst | Substrate | Product | S/C [a]; Time; Temp.; | % | Ref. [c] |
|---|---|---|---|---|---|---|
| 1 | 200; 0.5 h; 28 °C; 100 | 97 ( | [ | |||
| 2 | 200; 3 h; 28 °C; 99 | 95 ( | [ | |||
| 3 | 100; 20 h; 28 °C; > 99 | 97.7 (R) | [ | |||
| 4 | 200; 20 h; 28 °C; 99 | 98 ( | [ | |||
| 5 | 200; 15 h; r.t.; 99 | 97 ( | [ | |||
| 6 | 200; 7 h; 28 °C; 99 | 96 ( | [ | |||
| 7 | 200; 8 h; 28 °C; 99 | 84 ( | [ | |||
| 8 | 200; 12 h; 28 °C; 99 | 92 ( | [ |
[a] Molar ratio substrate/catalyst; [b] See corresponding references for details on determination of ee and product configuration; [c] Reference containing data for a given entry; [d] Catalyst was formed in situ from the [RuCl2(η6-arene)]2 dimer and the corresponding N-arylsulfonylethylene-1,2-diamine.
ATH of acetophenone catalyzed by 1b in water [a].
| Entry | Catalyst config. | Solution | Time; Temp.; Conversion (%) | % | Ref. [c] |
|---|---|---|---|---|---|
| 1 | ( | H2O/HCOONa | 2 h; 40 °C; >99 | 94 % ( | [ |
| 2 | ( | HCOOH/Et3N | 12 h; 40°C; 98 | 97 % ( | [ |
| 3 | ( | H2O/HCOONa/CTAB [d] | 4 h; 28 °C; >99 | 95 % ( | [ |
| 4 | ( | H2O/HCOONa/PEG | 15 h; 40 °C; >99 | 96 % ( | [ |
[a] Molar ratio substrate/catalyst (S/C) = 100; The catalyst was formed in situ from the [RuCl2(η6-p-cymene)]2 dimer and TsDPEN; [b] See corresponding references for details on determination of ee and product configuration; [c] Reference containing data for a given entry. [d] CTAB = cetyltrimethyl-ammonium bromide.
ATH of acetophenone catalyzed by immobilized 1b.
| Entry | Catalyst config. | Substrate | Solution | S/C [a]; Time; Temp.; | % | Ref. [c] |
|---|---|---|---|---|---|---|
| 1 | ( | DHIQ [e] | HCOOH/Et3N; acetonitrile | 200; 7 h; r.t.; 99 | 89% ( | [ |
| 2 | ( | acetophenone | H2O/HCOONa; Et4N+Br | 100; 5 h; 30 °C; >99 | 93% ( | [ |
[a] Molar ratio substrate/catalyst; [b] See corresponding references for details on determination of ee and product configuration; [c] Reference containing data for a given entry; [d] 1b was immobilized in functionalized MCM-41; [e] DHIQ = 1-methyl-3,4-dihydroisoquinoline; [f] 1b was immobilized in a nanocage of SBA-16.
Figure 2Modifications of TsDPEN used in ATH in water.
ATH of ketones and imines in water using modified diamine ligands [a].
| Entry | Ligand | Substrate | Solution | Time; Temp.; | % | Ref. [c] |
|---|---|---|---|---|---|---|
| 1 | ( | acetophenone | H2O/ | 48 h; 22 °C; 96 | 94 ( | [ |
| 2 | ( | acetophenone | H2O/HCOONa; SDS [d] | 24 h; 40 °C; >99 | 95 ( | [ |
| 3 | ( | H2O/CH2Cl2/HCOONa; SDS | 24 h; 28 °C; 87 (isol. yield) | 94 | [ | |
| 4 | ( | DHIQ [e] | H2O/HCOONa; CTAB [f] | 10 h; 28 °C; 97 (isol. yield) | 95 ( | [ |
| 5 | ( | acetophenone | H2O/HCOONa | 0.5 h; 28 °C; 33 | 95 ( | [ |
| 6 | ( | acetophenone | H2O/HCOONa | 2 h; 40 °C; 100 | 94 ( | [ |
| 7 | ( | acetophenone | H2O/HCOONa | 2 h; 40 °C; 100 | 92 ( | [ |
[a] Molar ratio substrate/catalyst (S/C) = 100; The catalyst was formed in situ from the [RuCl2(η6-p-cymene)]2 dimer and the corresponding ligand; [b] See corresponding references for details on determination of ee and product configuration; [c] Reference containing data for a given entry; [d] SDS = sodium dodecyl sulfate; [e] DHIQ = 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline; [f] CTAB = cetyltrimethylammonium bromide.
Scheme 2Metal-ligand bifunctional mechanism: ATH of benzaldehyde using 30 and i-PrOH [61].
ATH of ketones and imines using immobilized derivatives of 1 [a].
| Entry | Ligand | Substrate | Solution | S/C [b]; Time; Temp.; Conversion (%) | % | Ref. [d] |
|---|---|---|---|---|---|---|
| 1 | ( | acetophenone | 20; 48 h; – ; 23 | 84 ( | [ | |
| 2 | ( | acetophenone | HCOOH/Et3N/ | 100; 18 h; 30 °C; 71 | > 99 ( | [ |
| 3 | ( | acetophenone | HCOOH/Et3N | 100; 28 h; 30 °C; 95 | 96.7 ( | [ |
| 4 | ( | acetophenone | HCOOH/Et3N | 100; 20 h; 50 °C; 95 | 94 ( | [ |
| 5 | ( | acetophenone | H2O/HCOONa | 100; 1 h; 40 °C; 99 | 92 ( | [ |
| 6 | ( | acetophenone | HCOOH/Et3N | 100; 6 h; 40 °C; >99 | 97 ( | [ |
| 7 | ( | acetophenone | H2O/HCOONa; TBAB [e] | 100; 2 h; 40 °C; >99 | 96 ( | [ |
| 8 | ( | 2-cyano-acetophenone | HCOOH/Et3N | 100; 17 h; 30 °C; 98 (isol. yield) | 97 ( | [ |
| 9 | ( | DHIQ [f] | HCOOH/Et3N/CH2Cl2 | 100; 12 h; r.t.; 100 (isol. yield) | 91 ( | [ |
| 10 | ( | acetophenone | H2O/HCOONa | 100; 3 h; 40 °C; 100 | 98 ( | [ |
| 11 | ( | acetophenone | H2O/HCOONa | 100; 3 h; 40 °C; 100 | 98 ( | [ |
| 12 | ( | DHIQ [f] | H2O/HCOONa; CTAC [g] | 100; 24 h; r.t.; 69 | 94 ( | [ |
| 13 | ( | acetophenone | H2O/HCOONa | 100; 2 h; r.t.; >99 | 96 ( | [ |
| 14 | ( | DHIQ [f] | HCOOH/Et3N/CH2Cl2 | 100; 1.5 h; 40 °C; 99 | 94 ( | [ |
| 15 | ( | acetophenone | H2O/HCOONa | 100; 9 h; 40 °C; 100 | 97 ( | [ |
[a] The catalyst was formed in situ from the [RuCl2(η6-p-cymene)]2 dimer and the corresponding ligand; [b] Molar ratio substrate/catalyst; [c] See corresponding references for details on determination of ee and product configuration; [d] Reference containing data for a given entry. [e] TBAB = tetrabutylammonium bromide; [f] DHIQ = 6,7-dimethoxy-1-methyl-3,4-dihydroisoquinoline; [g] CTAC = cetyltributyl-ammonium chloride.
Figure 3Immobilized TsDPEN-based ligands (I).
Figure 4Immobilized TsDPEN-based ligands (II).
Scheme 4Major differences in ATH of ketones and imines using the catalyst (S,S)-1b.
ATH of acetophenone using dendritic catalysts [a].
| Entry | Ligand | Solution | Time; Temp.; Conversion (%) | % | Ref. [c] | |
|---|---|---|---|---|---|---|
| 1 | ( | HCOOH/Et3N | 20 h; 28 °C; >98 | 96.5 ( | [ | |
| 2 | ( | HCOOH/Et3N | 20 h; 28 °C; 99 | 97.6 ( | [ | |
| 3 | ( | HCOOH/Et3N | 20 h; 28 °C; 97 | 97.1 ( | [ | |
| 4 | ( | HCOOH/Et3N | 20 h; 28 °C; 97 | 97.1 ( | [ | |
| 5 | ( | HCOOH/Et3N/CH2Cl2 | 20 h; 28 °C; 97 | 96.1 ( | [ | |
| 6 | ( | 48 h; 25 °C; 65 | 95 ( | [ | ||
| 7 | ( | H2O/HCOONa; TBAI [g] | 4 h; 40 °C; > 99 | 97 ( | [ | |
[a] Molar ratio substrate/catalyst (S/C) = 100; The catalyst was formed in situ from the [RuCl2(η6-p-cymene)]2 dimer and the corresponding ligand; [b] See corresponding references for details on determination of ee and product configuration; [c] Reference containing data for a given entry; [d] For all generations (n = 1-3), similar performances were observed; [e] Data for the third generation (n = 3); [f] Data for the second generation (n = 2); [g] TBAI = tetrabutylammonium iodide.
Figure 5Dendritic TsDPEN-based ligands.
Figure 6Ligands designed for ATH in ionic liquids.
ATH of acetophenone performed in ionic liquids.
| Entry | Ligand | Solution | S/C [a]; Time; Temp.; | % | Ref. [c] |
|---|---|---|---|---|---|
| 1 | ( | HCOOH/Et3N/[C4C1C1Im]PF6 [e] | 200; 24 h; 35 °C; > 99 | > 99 | [ |
| 2 | ( | HCOOH/Et3N/[bmim][PF6] [g] | 100; 24 h; r.t.; 98 | 92 ( | [ |
| 3 | ( | HCOOH/Et3N/[bmim][PF6] [g] | 100; 8 h; 40 °C; 100 | 97 ( | [ |
[a] Molar ratio substrate/catalyst; [b] See corresponding references for details on determination of ee and product configuration; [c] Reference containing data for a given entry; [d] The catalyst was formed in situ from (R,R)-TsDPEN and the corresponding ligand; [e] 1-butyl-2,3-dimethylimidazolium hexafluoro-phosphate; [f] The catalyst was formed in situ from the [RuCl2(η6-benzene)]2 dimer and (S,S)-24; [g] [bmim][PF6] = 1-butyl-3-methylimidazolium hexafluorophosphate; [h] The catalyst was formed in situ from the [RuCl2(η6-p-cymene)]2 dimer and (R,R)-5a.
Figure 7Ligands and complexes in biomimetic applications.
Scheme 1The original metal-ligand bifunctional mechanistic concept [144].
Scheme 3Structures observed in the reaction mixture when HCOOH/triethylamine is used in ATH.
Figure 8Cut-off input geometries for TS optimization. The C(sp3)H/π interaction is shown in green. The unnecessary hydrogen atoms have been omitted for clarity.
Figure 9Optimized structures of favTSs utilizing C(sp3)H/π (41) or C(sp2)H/π (42) interactions (shown in green). The unnecessary hydrogen atoms have been omitted for clarity.